Reuters logo
BRIEF-Perrigo announces FDA final approval for its AB rated generic version of Exalgo® 32mg extended release tablets
September 21, 2017 / 1:38 PM / in a month

BRIEF-Perrigo announces FDA final approval for its AB rated generic version of Exalgo® 32mg extended release tablets

Sept 21 (Reuters) - Perrigo Company PLC

* Perrigo announces FDA final approval for its AB rated generic version of Exalgo® 32mg extended release tablets

* Perrigo announces FDA final approval for its AB rated generic version of Exalgo® 32mg extended release tablets

* Perrigo Company PLC - ‍company anticipates launching the product by end of September 2017​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below